company background image
532612 logo

Indoco Remedies BSE:532612 Stock Report

Last Price

₹332.20

Market Cap

₹30.6b

7D

-2.0%

1Y

-15.7%

Updated

28 Dec, 2024

Data

Company Financials +

Indoco Remedies Limited

BSE:532612 Stock Report

Market Cap: ₹30.6b

532612 Stock Overview

Manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. More details

532612 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance1/6
Financial Health3/6
Dividends3/6

Rewards

Trading at 41.5% below our estimate of its fair value

Earnings are forecast to grow 72.18% per year

Risk Analysis

High level of non-cash earnings

Interest payments are not well covered by earnings

Profit margins (1.8%) are lower than last year (6.5%)

Dividend of 0.45% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

Indoco Remedies Limited Competitors

Gujarat Themis Biosyn

BSE:506879

₹33.2b

RPG Life Sciences

NSEI:RPGLIFE

₹35.1b

Morepen Laboratories

BSE:500288

₹42.1b

Themis Medicare

BSE:530199

₹24.3b

Price History & Performance

Summary of share price highs, lows and changes for Indoco Remedies
Historical stock prices
Current Share Price₹332.20
52 Week High₹416.95
52 Week Low₹286.50
Beta0.37
1 Month Change5.39%
3 Month Change-7.02%
1 Year Change-15.74%
3 Year Change-26.79%
5 Year Change80.64%
Change since IPO529.17%

Recent News & Updates

Recent updates

Shareholder Returns

532612IN PharmaceuticalsIN Market
7D-2.0%1.7%0.2%
1Y-15.7%39.1%17.2%

Return vs Industry: 532612 underperformed the Indian Pharmaceuticals industry which returned 39.1% over the past year.

Return vs Market: 532612 underperformed the Indian Market which returned 17.2% over the past year.

Price Volatility

Is 532612's price volatile compared to industry and market?
532612 volatility
532612 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 532612 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 532612's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19456,000Sundeep Bambolkarwww.indoco.com

Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infectives, vitamins/minerals/nutrients, ophthal/ontological, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, as well as anti-haemorrhoidal creas and calcium preparations.

Indoco Remedies Limited Fundamentals Summary

How do Indoco Remedies's earnings and revenue compare to its market cap?
532612 fundamental statistics
Market cap₹30.59b
Earnings (TTM)₹320.60m
Revenue (TTM)₹17.73b

95.4x

P/E Ratio

1.7x

P/S Ratio

Is 532612 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
532612 income statement (TTM)
Revenue₹17.73b
Cost of Revenue₹6.23b
Gross Profit₹11.51b
Other Expenses₹11.18b
Earnings₹320.60m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)3.48
Gross Margin64.88%
Net Profit Margin1.81%
Debt/Equity Ratio75.2%

How did 532612 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

14%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 23:07
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Indoco Remedies Limited is covered by 16 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sriraam RathiAnand Rathi Shares and Stock Brokers Limited
Sarabjit NangraAngel Broking Private Limited
Srivathsan RamachandranAvendus Spark